173 related articles for article (PubMed ID: 34453531)
1. Does continuation of antifibrotics before lung transplantation influence post-transplant outcomes in patients with idiopathic pulmonary fibrosis?
Zhu MZL; Huang JY; Liu DH; Snell GI
Interact Cardiovasc Thorac Surg; 2022 Jan; 34(2):250-254. PubMed ID: 34453531
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series.
Delanote I; Wuyts WA; Yserbyt J; Verbeken EK; Verleden GM; Vos R
BMC Pulm Med; 2016 Nov; 16(1):156. PubMed ID: 27863518
[TBL] [Abstract][Full Text] [Related]
3. Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis.
Moncomble E; Weisenburger G; Picard C; Dégot T; Reynaud-Gaubert M; Nieves A; Mornex JF; Dauriat G; Messika J; Godet C; Hirschi S; Le Pavec J; Borie R; Mordant P; Lortat-Jacob B; Mal H; Bunel V
Respirology; 2024 Jan; 29(1):71-79. PubMed ID: 37789612
[TBL] [Abstract][Full Text] [Related]
4. Risk of anastomotic dehiscence in patients with pulmonary fibrosis transplanted while receiving anti-fibrotics: Experience of the Australian Lung Transplant Collaborative.
Mackintosh JA; Munsif M; Ranzenbacher L; Thomson C; Musk M; Snell G; Glanville A; Chambers DC; Hopkins P
J Heart Lung Transplant; 2019 May; 38(5):553-559. PubMed ID: 30824289
[TBL] [Abstract][Full Text] [Related]
5. Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review.
Bos S; De Sadeleer LJ; Vanstapel A; Beeckmans H; Sacreas A; Yserbyt J; Wuyts WA; Vos R
Eur Respir Rev; 2021 Jun; 30(160):. PubMed ID: 34415849
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotics and lung transplantation: A Spanish multicentre case-controlled study.
Mora Cuesta VM; Iturbe Fernández D; Aguado Ibáñez S; Anguera de Francisco G; Margallo Iribarnegaray J; Carrillo Hernández-Rubio J; Reig Mezquida JP; Pérez Luz V; Laporta Hernández R; de Pablo Gafas A; Solé Jover A; Cifrián Martínez JM
Respirology; 2022 Dec; 27(12):1054-1063. PubMed ID: 36053911
[TBL] [Abstract][Full Text] [Related]
7. Effect of antifibrotic therapy in patients with idiopathic pulmonary fibrosis undergoing lung transplant in the peri and post-operative period.
Dorey-Stein ZL; Shapiro W; Zhao H; Cordova FC; Criner GJ; Galli JA
Respir Med; 2021 Dec; 190():106599. PubMed ID: 34788735
[TBL] [Abstract][Full Text] [Related]
8. Real-World Study Analysing Progression and Survival of Patients with Idiopathic Pulmonary Fibrosis with Preserved Lung Function on Antifibrotic Treatment.
Noor S; Nawaz S; Chaudhuri N
Adv Ther; 2021 Jan; 38(1):268-277. PubMed ID: 33098554
[TBL] [Abstract][Full Text] [Related]
9. Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study.
Suzuki Y; Mori K; Aono Y; Kono M; Hasegawa H; Yokomura K; Naoi H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Nakamura H; Suda T
BMC Pulm Med; 2021 Jul; 21(1):221. PubMed ID: 34247593
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study.
Gershman E; Zer A; Pertzov B; Shtraichman O; Shitenberg D; Heching M; Rosengarten D; Kramer M
BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32565443
[TBL] [Abstract][Full Text] [Related]
11. Impact of ILD-Specific Therapies on Perioperative Course in Patients with Progressive Interstitial Lung Disease Undergoing Lung Transplantation.
Munker D; Arnold P; Leuschner G; Irlbeck M; Michel S; Kauke T; Meiser B; Behr J; Kneidinger N; Veit T
J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568398
[TBL] [Abstract][Full Text] [Related]
12. Lung transplant candidates with idiopathic pulmonary fibrosis and long-term pirfenidone therapy: Treatment feasibility influences waitlist survival.
Tanaka S; Miyoshi K; Higo H; Kurosaki T; Otani S; Sugimoto S; Yamane M; Kiura K; Toyooka S; Oto T
Respir Investig; 2019 Mar; 57(2):165-171. PubMed ID: 30600175
[TBL] [Abstract][Full Text] [Related]
13. Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy.
Leuschner G; Stocker F; Veit T; Kneidinger N; Winter H; Schramm R; Weig T; Matthes S; Ceelen F; Arnold P; Munker D; Klenner F; Hatz R; Frankenberger M; Behr J; Neurohr C
J Heart Lung Transplant; 2017 Jul; ():. PubMed ID: 28734935
[TBL] [Abstract][Full Text] [Related]
14. Impact of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplant Outcomes.
Warrior K; Sayad K; O'Hara CP; Dilling DF
Transplantation; 2024 Jun; 108(6):1460-1465. PubMed ID: 38291576
[TBL] [Abstract][Full Text] [Related]
15. Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment.
Fisher JH; Al-Hejaili F; Kandel S; Hirji A; Shapera S; Mura M
Respir Med; 2017 Apr; 125():65-71. PubMed ID: 28340864
[TBL] [Abstract][Full Text] [Related]
16. Pirfenidone exerts beneficial effects in patients with IPF undergoing single lung transplantation.
Veit T; Leuschner G; Sisic A; Ceelen F; Munker D; Schmitzer M; Weig T; Michel S; Schneider C; Meiser B; Crispin A; Neurohr C; Behr J; Milger K; Kneidinger N
Am J Transplant; 2019 Aug; 19(8):2358-2365. PubMed ID: 30942945
[TBL] [Abstract][Full Text] [Related]
17. Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis.
Astor TL; Goldberg HJ; Snyder LD; Courtwright A; Hachem R; Pena T; Zaffiri L; Criner GJ; Budev MM; Thaniyavarn T; Leonard TB; Bender S; Barakat A; Breeze JL; LaCamera P
Ther Adv Respir Dis; 2023; 17():17534666231165912. PubMed ID: 37073794
[TBL] [Abstract][Full Text] [Related]
18. Determinants of survival in lung transplantation patients with idiopathic pulmonary fibrosis: a retrospective cohort study.
Tuyls S; Verleden SE; Wuyts WA; Yserbyt J; Vos R; Verleden GM
Transpl Int; 2019 Apr; 32(4):399-409. PubMed ID: 30488486
[TBL] [Abstract][Full Text] [Related]
19. Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis.
Cilli A; Uzer F; Sevinç C; Coşkun F; Ursavaş A; Öner Ş; Kose F
Pulm Pharmacol Ther; 2021 Dec; 71():102099. PubMed ID: 34793978
[TBL] [Abstract][Full Text] [Related]
20. Ten-Year Survival in Patients with Idiopathic Pulmonary Fibrosis After Lung Transplantation.
ten Klooster L; Nossent GD; Kwakkel-van Erp JM; van Kessel DA; Oudijk EJ; van de Graaf EA; Luijk B; Hoek RA; van den Blink B; van Hal PT; Verschuuren EA; van der Bij W; van Moorsel CH; Grutters JC
Lung; 2015 Dec; 193(6):919-26. PubMed ID: 26404700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
